Oppenheimer cuts Aurinia to perform on M&A chatter, recent share price rise

seekingalpha2021-10-28

Oppenheimer has downgraded Aurinia Pharmaceuticals(NASDAQ:AUPH)from outperform to perform following a report thatthe company may be acquired by Bristol-Myers Squibb(NYSE:BMY). In addition, the firm ...

网页链接
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
20